Dr. Kryder is a proven executive in the healthcare information technology arena with decades of experience successfully leading and growing healthcare IT companies. He joins a highly qualified and experienced board of directors that includes Dr. Robert Wah, former president of the American Medical Association, and Peter Neupert, former General Manager of Microsoft Health and CEO of Drugstore.com.
Dr. Kryder takes on the role as executive chairman following the company’s latest fundraising round of $21.3 million from existing and new investors including Boston-based Flare Capital Partners, where Dr. Kryder is an executive partner, and Chicago-based 7wireVentures. With this latest investment, Dr. Kryder and the board will focus on accelerating the development of higi’s applications that connect consumers and their data directly into the workflow of at-risk healthcare organizations.
“It’s a terrific time to be in healthcare services, as technology – particularly remote diagnostics and monitoring – is improving the delivery of patient care, and as retail organizations are opening a new front door. higi’s machines meet consumers where they shop, and transmit data securely into the workflow of their doctors. This is likely to be a significant part of the future of healthcare, and I’m proud, as higi moves into high growth phase, to be part of it,” said Dr. Kryder.
Most recently, Dr. Kryder served as Chairman of Valence Health from 2012-2016, which merged with EvolentHealth (NASDAQ: EVH) in 2016. He was the Founder and CEO of the analytics vendor D2Hawkeye, and then CEO of Verisk Health after Verisk’s IPO (NASDAQ: VRSK) in 2009. Dr. Kryder also co-founded Generation Health, the first genetic testing benefits manager, which sold to CVS Caremark in 2010.
